OR WAIT null SECS
© 2023 MJH Life Sciences and Pharmaceutical Technology. All rights reserved.
© 2023 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.
March 01, 2016
The author lists five key areas to consider when selecting a CDMO to develop highly potent formulations.
November 02, 2015
The determination of topical bioequivalence requires a multi-faceted approach, tailored specifically to the generic-drug formulation.